Published Studies Related to Amiodarone Injection
Well-designed clinical trials related to Amiodarone Injection
Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation. [2009.09.15]
A randomized trial evaluating amiodarone for prevention of atrial fibrillation after pulmonary resection. [2009.09]
Intravenous diltiazem is superior to intravenous amiodarone or digoxin for achieving ventricular rate control in patients with acute uncomplicated atrial fibrillation. [2009.07]
Bioequivalence of 2 intravenous amiodarone formulations in healthy participants. [2009.04]
Prevention of atrial fibrillation after coronary artery bypass grafting via atrial electromechanical interval and use of amiodarone prophylaxis. [2009.04]
Effect of single intraoperative dose of amiodarone in patients with rheumatic valvular heart disease and atrial fibrillation undergoing valve replacement surgery. [2009.01]
Continuous vs episodic prophylactic treatment with amiodarone for the prevention of atrial fibrillation: a randomized trial. [2008.10.15]
Quality of life with defibrillator therapy or amiodarone in heart failure. [2008.09.04]
[Clinical efficacy of irbesartan and amiodarone in elderly patients with paroxysmal atrial fibrillation.] [2008.09]
Combination therapy with amiodarone and enalapril in patients with paroxysmal atrial fibrillation prevents the development of structural atrial remodeling. [2008.07]
Amiodarone protects diabetics and non-diabetics undergoing coronary artery bypass grafting equally. [2008.06]
Amiodarone cost effectiveness in preventing atrial fibrillation after coronary artery bypass graft surgery. [2008.01]
Intravenous and oral administration of amiodarone for the treatment of recent onset atrial fibrillation after digoxin administration. [2007.10.18]
Thyroid function abnormalities during amiodarone therapy for persistent atrial fibrillation. [2007.10]
Comparative study of intravenous amiodarone and procainamide in the treatment of atrial fibrillation of recent onset. [2007.08]
A comparative study of the efficacy and safety of procainamide versus propafenone versus amiodarone for the conversion of recent-onset atrial fibrillation. [2007.06.15]
Conversion efficacy of intravenous ibutilide compared with intravenous amiodarone in patients with recent-onset atrial fibrillation and atrial flutter. [2007.06.12]
The safety of amiodarone in patients with heart failure. [2007.06]
Absence of bilateral vision loss from amiodarone: a randomized trial. [2007.05]
Amiodarone interacts with simvastatin but not with pravastatin disposition kinetics. [2007.05]
Role of amiodarone on the systemic inflammatory response induced by cardiac surgery: proinflammatory actions: [Role de l'amiodarone sur la reaction inflammatoire systemique provoquee par la chirurgie cardiaque : actions pro-inflammatoires]. [2007.04]
Practical regimen for amiodarone use in preventing postoperative atrial fibrillation. [2007.04]
Exercise capacity in atrial fibrillation: a substudy of the Sotalol-Amiodarone Atrial Fibrillation Efficacy Trial (SAFE-T). [2007.04]
[Comparison between therapeutic effects of acupuncture and intravenous injection of amiodarone in the treatment of paroxymal atrial fibrillation and atrial flutter] [2007.02]
Monophasic versus biphasic waveform shocks for atrial fibrillation cardioversion in patients with concomitant amiodarone therapy. [2007.02]
Comparative bioavailability study with two amiodarone tablet formulations administered with and without food in healthy subjects. [2007]
Long-term efficacy and safety of very-low-dose amiodarone treatment for the maintenance of sinus rhythm in patients with chronic atrial fibrillation after successful direct-current cardioversion. [2006.12.20]
Results from the Loire-Ardeche-Drome-Isere-Puy-de-Dome (LADIP) trial on atrial flutter, a multicentric prospective randomized study comparing amiodarone and radiofrequency ablation after the first episode of symptomatic atrial flutter. [2006.10.17]
Effect of low-dose amiodarone and magnesium combination on atrial fibrillation after coronary artery surgery. [2006.09]
High dose of amiodarone in a short-term period reduces the incidence of postoperative atrial fibrillation and atrial flutter. [2006.09]
Prospective randomized study comparing amiodarone vs. amiodarone plus losartan vs. amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation. [2006.08]
Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial. [2006.07.11]
Amiodarone prophylaxis for atrial fibrillation of high-risk patients after coronary bypass grafting: a prospective, double-blinded, placebo-controlled, randomized study. [2006.07]
Effects of a high dose intravenous bolus amiodarone in patients with atrial fibrillation and a rapid ventricular rate. [2006.06.07]
Safety of amiodarone in the prevention of postoperative atrial fibrillation: a meta-analysis. [2006.05.01]
Design and rationale of a randomized study to compare amiodarone and Class IC anti-arrhythmic drugs in terms of atrial fibrillation treatment efficacy in patients paced for sinus node disease: the PITAGORA trial. [2006.04]
A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned. [2006.04]
Japanese randomized trial for investigation of a combined therapy of amiodarone and implantable cardioverter defibrillator in patients with ventricular tachycardia and fibrillation: the Nippon ICD Plus Pharmachologic Option Necessity study design. [2006.03]
Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial. [2006.01.11]
Economic analysis of intravenous plus oral amiodarone, atrial septal pacing, and both strategies to prevent atrial fibrillation after open heart surgery. [2004.08]
Effect of right atrial pacing, intravenous amiodarone and beta blockers for suppression of atrial fibrillation after coronary artery bypass surgery: a pilot study. [2003.06]
Amiodarone reduces the incidence of atrial fibrillation after coronary artery bypass grafting. [2003.06]
Comparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythm. [2000.11.01]
Intravenous amiodarone for prevention of atrial fibrillation after coronary artery bypass grafting. [2000.07]
Intraoperative amiodarone as prophylaxis against atrial fibrillation after coronary operations. [2000.05]
Intravenous amiodarone for ventricular arrhythmias: overview and clinical use. [1998.10]
The efficacy and safety of intravenous propafenone versus intravenous amiodarone in the conversion of atrial fibrillation or flutter after cardiac surgery. [1996.02]
Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. Intravenous Amiodarone Multicenter Trial Group. [1996.01]
Intravenous amiodarone vs propafenone for atrial fibrillation and flutter after cardiac operation. [1995]
Intravenous amiodarone bolus versus oral quinidine for atrial flutter and fibrillation after cardiac operations. [1990.05]
Propafenone versus amiodarone in field treatment of primary atrial tachydysrhythmias. [1990.01]
Intravenous amiodarone in acute anterior myocardial infarction: a controlled study. [1989.01]
A randomized hemodynamic comparison of intravenous amiodarone with and without Tween 80. [1988.02]
Well-designed clinical trials possibly related to Amiodarone Injection
Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population. [2009.09.08]
A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study). [2009.06]
The Antiarrhythmic Properties of Quifenadine, H1-Histamine Receptor Blocker in Children with Premature Beats: A Randomized Controlled Pilot Trial. [2009.05.30]
Image integration-guided catheter ablation of atrial fibrillation: a prospective randomized study. [2009.03]
Effect of dronedarone on cardiovascular events in atrial fibrillation. [2009.02.12]
Systematic electrocardioversion for atrial fibrillation and role of antiarrhythmic drugs: a substudy of the SAFE-T trial. [2009.02]
Ejection fraction assessment and survival: an analysis of the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). [2008.12]
Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy. [2008.11.11]
Severe atrioventricular decoupling, uncoupling, and ventriculoatrial coupling during enhanced atrial pacing: incidence, mechanisms, and implications for minimizing right ventricular pacing in ICD patients. [2008.11]
Rate-responsive pacing in patients with heart failure: long-term results of a randomized study. [2008.10]
Absence of protective effect of renin-angiotensin system inhibitors on atrial fibrillation development: insights from the Canadian Trial of Atrial Fibrillation (CTAF). [2008.09]
Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) study. [2008.09]
No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). [2008.08.12]
Right pectoral implantable cardioverter defibrillators: role of the proximal (SVC) coil. [2008.08]
Transvenous, intracardial cardioversion for the treatment of postoperative atrial fibrillation. [2008.07]
Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial. [2008.07]
Increased mortality after dronedarone therapy for severe heart failure. [2008.06.19]
Rhythm control versus rate control for atrial fibrillation and heart failure. [2008.06.19]
Combination pharmacological cardioversion of permanent atrial fibrillation in post-prosthetic mitral valve replacement outpatients: a novel approach for the treatment of atrial fibrillation. [2008.05]
Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study. [2008.04.01]
Effects of carvedilol on left ventricular function and oxidative stress in infants and children with idiopathic dilated cardiomyopathy: a 12-month, two-center, open-label study. [2008.04]
Outcome in African Americans and other minorities in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). [2008.03]
Comparative Evaluation of Effect of Valsartan/Amlodipine and Atenolol/Amlodipine Combinations on Atrial Fibrillation Recurrence in Hypertensive Patients With Type 2 Diabetes Mellitus. [2008.03]
Potential use of statins to prevent atrial fibrillation after coronary artery bypass surgery. [2008.02]
Potential Use of Statins to Prevent Atrial Fibrillation After Coronary Artery Bypass Surgery (February). [2008.01.15]
Rationale and design of ATHENA: A placebo-controlled, double-blind, parallel arm Trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular Hospitalization or death from any cause in patiENts with Atrial fibrillation/atrial flutter. [2008.01]
[Impact of electrical shock waveform and paddle positions on efficacy of direct current cardioversion for atrial fibrillation] [2008]
Effect of dronedarone on renal function in healthy subjects. [2007.12]
Thiazolidinedione use and post-operative atrial fibrillation: a US nested case-control study. [2007.11]
Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. [2007.09.06]
Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias. [2007.07]
Where patients with mild to moderate heart failure die: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). [2007.06]
Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). [2007.05.22]
Effect of preoperative angiotensin converting enzyme inhibitor or angiotensin receptor blocker use on the frequency of atrial fibrillation after cardiac surgery: a cohort study from the atrial fibrillation suppression trials II and III. [2007.05]
Adjunctive antiarrhythmic drug therapy in patients with implantable cardioverter defibrillators: a systematic review. [2007.02]
Impact of epicardial anterior fat pad retention on postcardiothoracic surgery atrial fibrillation incidence: the AFIST-III Study. [2007.01.23]
Antiarrhythmic drug therapy after radiofrequency catheter ablation in patients with atrial fibrillation. [2007.01]
A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. [2006.12.05]
Is circumferential pulmonary vein isolation preferable to stepwise segmental pulmonary vein isolation for patients with paroxysmal atrial fibrillation? [2006.11]
Pulmonary vein isolation and linear lesions in atrial fibrillation ablation. [2006.11]
Determinants of sudden cardiac death in patients with persistent atrial fibrillation in the rate control versus electrical cardioversion (RACE) study. [2006.10.01]
Dose-dependent effects of oral dronedarone on the circadian variation of RR and QT intervals in healthy subjects: implications for antiarrhythmic actions. [2006.09]
Quality of life and exercise performance in patients in sinus rhythm versus persistent atrial fibrillation: a Veterans Affairs Cooperative Studies Program Substudy. [2006.08.15]
[The clinical study of circumferential ablation around orifice of pulmonary vein by radiofrequency energy with chronic atrial fibrillation undergoing rheumatic valvular heart surgery] [2006.07.15]
Randomized trial to improve laboratory safety monitoring of ongoing drug therapy in ambulatory patients. [2006.05]
Decreased mortality in a rat model of acute postinfarction heart failure. [2006.03.10]
Circumferential pulmonary-vein ablation for chronic atrial fibrillation. [2006.03.02]
Effects of Thrombolysis During Out-of-Hospital Cardiopulmonary Resuscitation. [2006.02.01]
|
